Publisher Retracts Dozens of Studies

Springer Nature pulls 58 articles in one fell swoop, citing plagiarism and authorship manipulation, among other things.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, PHILLIP WONGSpringer and BioMed Central today (November 1) announced the retraction of 58 articles across seven journals, affecting more than 200 authors. Springer Nature, the company behind both subsidiary publishers, issued the mass retraction notice upon discovering that some of the now-pulled papers’ authors had manipulated the peer review process, and that some of the reports contained plagiarism.

“We take every allegation seriously, and investigate every allegation of plagiarism,” a Springer Nature spokesperson told Retraction Watch. “In this case we identified irregularities which led us to suspect a broader pattern of manipulation.”

While most retractions are quiet, single-study affairs, in recent years publishers have issued an increasing number of mass retractions. In 2014, for instance, Springer and IEEE pulled more than 120 papers that had been produced by SciGen, a random study generator.

But the most recent cases of misconduct reported by Springer Nature were more difficult to detect. “A much more complex manipulation has taken place from a different group of authors,” the publisher’s spokesperson told Retraction Watch. “It involves complex manipulation of our submission and peer reviews systems.”

Tumor Biology and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Joshua A. Krisch

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo